Role of glycogen synthase kinase 3 beta (GSK3beta) in mediating the cytotoxic effects of the histone deacetylase inhibitor trichostatin A (TSA) in MCF-7 breast cancer cells
- PMID: 17018141
- PMCID: PMC1592505
- DOI: 10.1186/1476-4598-5-40
Role of glycogen synthase kinase 3 beta (GSK3beta) in mediating the cytotoxic effects of the histone deacetylase inhibitor trichostatin A (TSA) in MCF-7 breast cancer cells
Abstract
Histone deacetylase inhibitors (HDACIs) have been shown to induce apoptotic and autophagic cell death in vitro and in vivo. The molecular mechanisms that underlie these cytotoxic effects are not yet clearly understood. Recently, HDACIs were shown to induce Akt dephosphorylation by disrupting HDAC-protein phosphatase 1 (PP1) complexes. This disruption results in the increased association of PP1 with Akt, resulting in the dephosphorylation and consequent inactivation of the kinase. Akt enhances cellular survival through the phosphorylation-dependent inhibition of several pro-apoptotic proteins. Akt is an important negative regulator of GSK3beta, a kinase that has been shown to regulate apoptosis in response to various stimuli. In the present study, we investigated the role of GSK3beta in mediating the cytotoxic effects in MCF-7 breast cancer cells treated with trichostatin A (TSA), a prototype HDACI. We show that TSA induces Akt dephosphorylation in a PP1-dependent manner, resulting in activation of GSK3beta in MCF-7 cells. Similarly, knockdown of HDAC1 and-2 by small interfering RNA (siRNA) resulted in the dephosphorylation of Akt and GSK3beta. Selective inhibition of GSK3beta attenuated TSA induced cytotoxicity and resulted in enhanced proliferation following drug removal. Our findings identify GSK3beta as an important mediator of TSA-induced cytotoxicity in MCF-7 breast cancer cells.
Figures

Similar articles
-
Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells.Mol Cancer. 2006 Feb 20;5:8. doi: 10.1186/1476-4598-5-8. Mol Cancer. 2006. PMID: 16504004 Free PMC article.
-
Histone acetylation-independent effect of histone deacetylase inhibitors on Akt through the reshuffling of protein phosphatase 1 complexes.J Biol Chem. 2005 Nov 18;280(46):38879-87. doi: 10.1074/jbc.M505733200. Epub 2005 Sep 26. J Biol Chem. 2005. PMID: 16186112
-
Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.Int J Oncol. 2006 Jul;29(1):269-78. Int J Oncol. 2006. PMID: 16773209
-
Regulation of AKT phosphorylation by GSK3β and PTEN to control chemoresistance in breast cancer.Breast Cancer Res Treat. 2019 Jul;176(2):291-301. doi: 10.1007/s10549-019-05239-3. Epub 2019 Apr 20. Breast Cancer Res Treat. 2019. PMID: 31006103
-
An emerging strategy for cancer treatment targeting aberrant glycogen synthase kinase 3 beta.Anticancer Agents Med Chem. 2009 Dec;9(10):1114-22. doi: 10.2174/187152009789734982. Anticancer Agents Med Chem. 2009. PMID: 19925395 Review.
Cited by
-
The extracellular HDAC6 ZnF UBP domain modulates the actin network and post-translational modifications of Tau.Cell Commun Signal. 2021 May 1;19(1):49. doi: 10.1186/s12964-021-00736-9. Cell Commun Signal. 2021. PMID: 33933071 Free PMC article.
-
Advances in Molecular Mechanisms of Kidney Disease: Integrating Renal Tumorigenesis of Hereditary Cancer Syndrome.Int J Mol Sci. 2024 Aug 21;25(16):9060. doi: 10.3390/ijms25169060. Int J Mol Sci. 2024. PMID: 39201746 Free PMC article. Review.
-
Autophagy and apoptosis cascade: which is more prominent in neuronal death?Cell Mol Life Sci. 2021 Dec;78(24):8001-8047. doi: 10.1007/s00018-021-04004-4. Epub 2021 Nov 6. Cell Mol Life Sci. 2021. PMID: 34741624 Free PMC article. Review.
-
Keratin 19 interacts with GSK3β to regulate its nuclear accumulation and degradation of cyclin D3.Mol Biol Cell. 2021 Nov 1;32(21):ar21. doi: 10.1091/mbc.E21-05-0255. Epub 2021 Aug 18. Mol Biol Cell. 2021. PMID: 34406791 Free PMC article.
-
GSK-3 as potential target for therapeutic intervention in cancer.Oncotarget. 2014 May 30;5(10):2881-911. doi: 10.18632/oncotarget.2037. Oncotarget. 2014. PMID: 24931005 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous